Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-17

Clinical Trial Update: Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rivaroxaban with enoxaparin for thromboprophylaxis in orthopedic surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lovenox (enoxaparin)
  • Xarelto (rivaroxaban)

Snippet

Sponsor: Ahmed AbdelMoneim Hassan Ali | Conditions: Thromboses, Deep Vein, Surgery--Complications | Phase 3 | Status: UNKNOWN